
    
      A multicenter, single arm, cohort study to evaluate the Efficacy and Safety of saxagliptin
      5mg, once daily for 24 weeks, in patients with type 2 diabetes mellitus who are treatment
      naive or who have inadequate glycaemic control on metformin alone
    
  